Table 2.
IMLs n=10 | Melanomas n=10 | P-valuea | Other choroidal tumors n=10 | P-valuea | P-valueb | |
---|---|---|---|---|---|---|
Sex | ||||||
Male | 6 (60%) | 2 (20%) | 3 (30%) | |||
Female | 4 (40%) | 8 (80%) | 0.170 | 7 (70%) | 0.370 | 0.635 |
Age (years) | ||||||
Mean ± SD | 65±10 | 69±15 | 51±22 | |||
Median (min–max) | 64 (53–85) | 70 (44–93) | 0.393 | 55 (18–74) | 0.393 | 0.075 |
Affected eye | ||||||
OD | 5 (50%) | 5 (50%) | 3 (30%) | |||
OS | 5 (50%) | 5 (50%) | 1.000 | 7 (70%) | 0.650 | 0.650 |
Visual acuity (logMAR) | ||||||
Mean ± SD | 0.31±0.26 | 0.49±0.62 | 0.30±0.40 | |||
Median (min–max) | 0.18 (0.0–0.7) | 0.30 (0.0–2.0) | 0.729 | 0.15 (0.0–1.22) | 0.529 | 0.481 |
Tumor location distance to optic nerve (mm) | ||||||
Mean ± SD | 3.1±2.5 | 2.8±2.2 | 1.9±2.5 | |||
Median (min–max) | 3.2 (0.0–7.5) | 2.6 (0.0–6.7) | 0.853 | 1.1 (0.0–7.8) | 0.280 | 0.218 |
Distance to foveola (mm) | ||||||
Mean ± SD | 1.6±2.8 | 1.5±1.9 | 1.6±2.4 | |||
Median (min–max) | 0.6 (0.0–7.5) | 0.5 (0.0–5.4) | 1.000 | 0.0 (0.0–6.0) | 0.796 | 0.853 |
Tumor thickness (mm) | ||||||
Mean ± SD | 2.6±0.5 | 3.6±2.6 | 2.6±1.4 | |||
Median (min–max) | 2.4 (1.9–3.3) | 3.1 (1.9–11.0) | 0.280 | 2.7 (1.0–4.6) | 1.000 | 0.579 |
Largest basal diameter of tumor (mm) | ||||||
Mean ± SD | 7.5±3.3 | 8.6±3.1 | 7.4±3.3 | |||
Median (min–max) | 8.3 (1.6–11.4) | 8.6 (3.7–13.3) | 0.481 | 7.0 (3.1–14.5) | 0.739 | 0.353 |
Follow-up | ||||||
Mean ± SD | 16.9±4.8 | 10.4±5.5 | 10.7±4.8 | |||
Median (min–max) | 17.5 (7–22) | 7.5 (6–20) | 0.011* | 10.5 (5–19) | 0.015* | 0.853 |
Notes:
P-value, IML vs melanoma and other choroidal tumors;
P-value, melanoma vs other choroidal tumors.
denotes statistical significance.
Abbreviations: IML, indeterminate choroidal melanocytic lesion; logMAR, logarithm of the minimum angle of resolution; OD, right eye; OS, left eye; SD, standard deviation.